Newsroom | 4980 results

SAN DIEGO--(BUSINESS WIRE)--Tandem t:slim mobile application is now available for Android and iOS users in Canada....

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq : TNDM) un chef de file de l'administration d'insuline et de la technologie du diabète, annonce aujourd'hui la disponibilité de l'application mobile Tandem t:slim pour les utilisateurs d'Android et d'iOS au Canada. L'application mobile Tandem t:slim permet aux utilisateurs d’administrer un bolus à partir de leur téléphone intelligent compatible et de télécharger sans fil leurs données de pompe sur la plateforme Tandem Source basée s...

WASHINGTON--(BUSINESS WIRE)--New national and state data released today by the Partnership to Fight Chronic Disease (PFCD) projects that chronic disease is on pace to cost the United States as much as $47 trillion between 2024 and 2039, including $2.2 trillion annually in medical costs and nearly $900 billion each year in lost productivity by 2039. The analysis, conducted by GlobalData, highlights a stark reality: 5% of people account for nearly 50% of total health care spending, driven largely...

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases, today announced that Jason Ehrlich, M.D., Ph.D., co-founder and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 4:00 p.m. PT. Dr. Ehrlich will provide an overview of the company’s pipeline, including OLN324, a higher potency, higher molar...

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts and advancing the science of tissue transplantation, today announced that two of its aseptically processed allografts without terminal irradiation, AmnioBand® Membrane, an allograft placental matrix, and AlloPatch® Pliable an allograft dermal matrix, will remain among the 18 tissues covered under the newly updated Medicare Local Coverage Determinations (LCDs) for sk...

SAN MATEO, Calif.--(BUSINESS WIRE)--Evidation, the leader in direct-from-participant real-world data and health research, is announcing new preliminary insights suggesting that nearly 1 in 7 injectable GLP-1 users are microdosing, that microdosing is largely patient-driven, and that there are multiple relevant influences driving microdosing decisions. Evidation has been conducting ongoing, multimodal, participant-consented research within a discrete cohort of over 160,000 individuals who are ac...

LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will highlight how advances in cancer research and treatment are bringing hope to cancer patients and survivors everywhere with a remarkable float and six inspiring riders in the 2026 Rose Parade on Jan. 1. The float, titled “Overcoming Can...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced the appointment of Aneesh Chopra, Dr. Rajendra Gupta, and Sean Murphy as strategic advisors. The new advisors will leverage their deep expertise in technology transformation, public policy, global health, and corporate growth to guide Welldoc’s strategic initiatives and market expansion in support of the company’s mission to empower better cardiometabolic health through AI-powered,...

LOS ANGELES--(BUSINESS WIRE)--Cancer is complex, with a future full of both promise and uncertainty. From artificial intelligence transforming data into lifesaving insights to gut microbiome-guided therapies that turn food into medicine, experts at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, share five predictions for how scientific innovation will continue to transform cancer treatment and survivorship in 2026. These bre...

LONDON & GLASGOW, Scotland--(BUSINESS WIRE)--Glasgow Caledonian University has secured £2.6 million to lead a major new UK-wide doctoral training programme to spearhead research into oral health and dental disease prevention. Funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and delivered in partnership with Haleon, a consumer company focused on better everyday health, the six-year initiative will support 20 PhD students across five universities. Students will investi...